Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q1 2022 Resul

Lantern Pharma Inc. (NASDAQ:NASDAQ:LTRN) Q1 2022 Earnings Conference Call May 3, 2022 16:30 ET Company Participants Nicole Leber - Investor Relations Associate, Finance & Administrative...

Related Keywords

University Of Texas , Texas , United States , Australia , San Antonio , Australian , Keith Thompson , Michael Samuels , Maria Maccecchini , Kishor Bhatia , Peter Houghton , Nicole Leber , John Newman , Company Participants , University Of Texas Health Science Center , Annovis Bio Inc , International Journal Of Cancer , Lantern Pharma Australia , Children Cancer Research Institute , Nasdaq , Lantern Pharma Inc , Greehey Children Cancer Institute , Lantern Pharma , Conference Call May , Relations Associate , Chief Executive , Financial Officer , Scientific Officer , Investor Relations , First Quarter , Private Securities Litigation Reform Act , Annual Report , Panna Sharma , David Margrave , Chief Scientific Officer , Cancer Research Institute , Greehey Children , Cancer Institute , Texas Health Science Center , Lantern Pharma Australia Limited , International Journal ,